S100A12 and bronchopulmonary dysplasia: In this study, the expression level of S100A12 in two BPD validation datasets (5 days and 14 days after birth) was higher than that in the control group, indicating that S100A12 is a very important pathogenic factor in the entire BPD pathogenesis.